Forty male rats were allocated into four groups: control, diabetic (STZ), diabetic treated with semaglutide (0.9 mg/kg), and diabetic treated with semaglutide (0.3 mg/kg) combined with 10% papaya juice for eight weeks
This is supported by a recent survey of individuals receiving GLP-1RAs, in which some participants reported reduced food noise, alongside improved satiety and an increased ability to adopt healthier eating habits [7]
Essentially there were three to four extra cases of ischemic optic neuropathy per 10,000 patients in the GLP-1 compared with the other groups
MH: writing (original draft, review, and editing)
A multicentre retrospective study from China found that high fasting glucose levels (7.0 mmol/l (126 mg/dl)) at admission was an independent predictor of increased mortality in patients with COVID-19 who did not have diabetes mellitus 61